Mirum Pharmaceuticals (MIRM) Stock Chart & Stock Price History $52.02 +0.34 (+0.66%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$52.01 -0.01 (-0.02%) As of 08/1/2025 05:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Mirum Pharmaceuticals Stock Price Performance The Mirum Pharmaceuticals (MIRM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 32.10%, with a year-to-date return of 25.80%. In the past month, the stock has increased 4.19%, reflecting recent market activity. As of the latest close, Mirum Pharmaceuticals traded at $52.02 with a market cap of $2.58 billion and volume of 337,696 shares. Five years ago, the stock traded at $22.49, representing a 131.30% increase over that period. At the time, it had a market cap of $571.02 million and a volume of 199,817 shares. Receive MIRM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Mirum Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.66%1 Month Performance+4.19%3 Month Performance+19.07%Year-To-Date Performance+25.80%1 Year Performance+32.10%5 Year Performance+131.30% MIRM Stock Chart for Sunday, August, 3, 2025 MIRM Chart by TradingView Mirum Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$51.68$52.02+0.66%$52.74$51.33337,696 shs$2.58 billion07/31/2025$51.12$51.68+1.10%$52.60$50.75325,654 shs$2.56 billion07/30/2025$51.17$51.12-0.10%$52.49$51.01406,940 shs$2.53 billion07/29/2025$51.49$51.17-0.62%$52.24$50.92304,174 shs$2.53 billion07/28/2025$51.83$51.49-0.66%$52.63$51.36252,407 shs$2.55 billion07/25/2025$52.17$51.83-0.65%$52.33$51.22247,804 shs$2.57 billion07/24/2025$53.05$52.17-1.66%$53.78$52.12294,535 shs$2.58 billion07/23/2025$52.19$53.05+1.65%$53.63$51.60415,785 shs$2.63 billion07/22/2025$51.95$52.19+0.46%$52.28$50.96335,380 shs$2.58 billion07/21/2025$51.93$51.95+0.04%$52.75$51.08267,200 shs$2.57 billion Get the Latest News and Ratings for MIRM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mirum Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$52.73$51.93-1.52%$53.07$51.81255,993 shs$2.57 billion07/17/2025$52.80$52.73-0.13%$53.19$52.52256,864 shs$2.61 billion07/16/2025$51.98$52.80+1.58%$53.59$52.12372,680 shs$2.62 billion07/15/2025$53.28$51.98-2.44%$53.46$51.73313,298 shs$2.57 billion07/14/2025$52.66$53.28+1.18%$54.78$52.55705,635 shs$2.64 billion07/11/2025$53.01$52.66-0.66%$53.91$52.25320,943 shs$2.61 billion07/10/2025$53.46$53.01-0.84%$53.60$52.38379,718 shs$2.63 billion07/09/2025$50.27$53.46+6.35%$53.86$50.69703,097 shs$2.65 billion07/08/2025$50.47$50.27-0.40%$50.81$49.22298,606 shs$2.49 billion07/07/2025$49.93$50.47+1.08%$50.75$49.60581,615 shs$2.50 billion07/04/2025$49.93$49.93$50.41$49.01216,684 shs$2.47 billion07/03/2025$49.09$49.93+1.71%$50.41$49.01216,684 shs$2.47 billion07/02/2025$48.39$49.09+1.45%$49.33$47.89461,981 shs$2.43 billion Related Companies Ascendis Pharma A/S Stock Chart BridgeBio Pharma Stock Chart Verona Pharma PLC American Depositary Share Stock Chart Blueprint Medicines Stock Chart Legend Biotech Stock Chart Roivant Sciences Stock Chart Regencell Bioscience Stock Chart Elanco Animal Health Stock Chart Revolution Medicines Stock Chart Grifols Stock Chart Receive MIRM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Mirum Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MIRM) was last updated on 8/3/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredIf you saw this, you'd be scared tooMarkets may look strong—but one veteran analyst warns we’re nearing a financial breaking point. After 40+ y...InvestorPlace | SponsoredWhy “The Prophet” Is Betting Big on This $10 StockAmerica's Biggest Land Grab Is Not Where You Think While the media focuses on coastal cities and farmland.....Stansberry Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mirum Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mirum Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MIRM Stock Alerts